Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures

Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures

Source: Jan Antonin Kolar/Unsplash

Biopharmaceutical firm Hangzhou DAC Biotech Co., Ltd has announced the completion of a 1 billion yuan ($156 million) Series C round co-led by PE firm Hillhouse Capital’s venture unit GL Ventures.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter